Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Shares Outstanding (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Shares Outstanding for 3 consecutive years, with $24.6 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 1.25% to $24.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $24.6 million through Dec 2025, up 1.25% year-over-year, with the annual reading at $24.6 million for FY2025, 1.25% up from the prior year.
  • Shares Outstanding for Q4 2025 was $24.6 million at Artiva Biotherapeutics, up from $424000.0 in the prior quarter.
  • The five-year high for Shares Outstanding was $24.6 million in Q4 2025, with the low at $424000.0 in Q3 2025.
  • Average Shares Outstanding over 3 years is $11.8 million, with a median of $3.7 million recorded in 2024.
  • Peak annual rise in Shares Outstanding hit 2908.69% in 2025, while the deepest fall reached 1.06% in 2025.
  • Over 3 years, Shares Outstanding stood at $809758.0 in 2023, then skyrocketed by 2899.86% to $24.3 million in 2024, then grew by 1.25% to $24.6 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $24.6 million, $24.5 million, and $24.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.